Tandem Diabetes Care, Inc. (TNDM) Social Stream
TANDEM DIABETES CARE INC (TNDM) Price Targets From Analysts
Use the tables below to see what analysts covering TANDEM DIABETES CARE INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 10 | $154 | $90 | $127.3 | $40.74 | 212.47% |
| 2021-12-06 | 9 | $154 | $90 | $128.111 | $40.74 | 214.46% |
| 2021-12-19 | 7 | $170 | $90 | $133.5 | $40.74 | 227.69% |
| 2022-02-23 | 8 | $170 | $90 | $136.444 | $40.74 | 234.91% |
| 2022-02-24 | 8 | $170 | $90 | $135.375 | $40.74 | 232.29% |
| 2022-03-01 | 8 | $170 | $90 | $134.777 | $40.74 | 230.82% |
| 2022-05-06 | 9 | $160 | $90 | $126.666 | $40.74 | 210.91% |
| 2022-05-17 | 9 | $160 | $90 | $123.6 | $40.74 | 203.39% |
| 2022-08-05 | 7 | $150 | $72 | $97.6 | $40.74 | 139.57% |
| 2022-08-13 | 7 | $150 | $49 | $94.3 | $40.74 | 131.47% |
| 2022-09-19 | 7 | $150 | $49 | $92.8 | $40.74 | 127.79% |
| 2022-10-05 | 7 | $150 | $49 | $90.5 | $40.74 | 122.14% |
| 2022-10-12 | 8 | $150 | $49 | $89.09 | $40.74 | 118.68% |
| 2022-10-18 | 9 | $150 | $49 | $87.916 | $40.74 | 115.8% |
| 2022-11-03 | 9 | $150 | $45 | $71.923 | $40.74 | 76.54% |
| 2022-11-04 | 9 | $80 | $45 | $61.923 | $40.74 | 52% |
| 2022-11-08 | 9 | $80 | $45 | $61.077 | $40.74 | 49.92% |
| 2022-11-15 | 9 | $80 | $43.001 | $60.615 | $40.74 | 48.78% |
| 2023-01-26 | 9 | $80 | $43.001 | $59.077 | $40.74 | 45.01% |
The Trend in the Analyst Price Target
Over the past 32 months, TNDM's average price target has gone down $31.61.
TNDM reports an average of 59.56% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-23 | 8 | 170 | 90 | 136.444 | 104.20 | 30.94% |
| 2022-02-24 | 6 | 170 | 90 | 135.375 | 110.20 | 22.84% |
| 2022-05-17 | 7 | 160 | 100 | 127.333 | 74.71 | 70.44% |
| 2022-05-17 | 9 | 160 | 90 | 123.600 | 74.71 | 65.44% |
| 2022-08-05 | 7 | 150 | 72 | 97.600 | 59.54 | 63.92% |
TNDM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.78 | 5 | 1 | 3 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
TNDM's average broker recommendation rating improved by 0.46 over the prior 17 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TNDM as an investment opportunity.
- In the context of all US stocks, TANDEM DIABETES CARE INC's upside potential (average analyst target price relative to current price) is greater than 2637.64% of them.
- In terms of how TANDEM DIABETES CARE INC fares relative to all US stocks, note that its average analyst price target is higher than 2413.73% of that group.
- TANDEM DIABETES CARE INC's variance in analysts' estimates is lower than -2308.57% of Medical Equipment stocks.
- TANDEM DIABETES CARE INC's number of analysts covering the stock is higher than 1858.82% of stocks in the mid market cap category.
Stocks similar to TANDEM DIABETES CARE INC in the Medical Equipment industry regarding analyst recommendations and price targets are NVRO, ATRC, and GMED.
View All Top Stocks by Price Target
Make investment decisions regarding TNDM using the data that counts. Try POWR Ratings for free.